Jacob Asset Management of New York’s TELA Bio TELA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$1.28M Buy
159,775
+4,000
+3% +$37.2K 1.8% 21
2023
Q2
$1.58M Buy
155,775
+5,000
+3% +$51.1K 1.78% 23
2023
Q1
$1.6M Buy
150,775
+37,000
+33% +$408K 1.87% 22
2022
Q4
$1.31M Sell
113,775
-2,320
-2% -$20.8K 1.59% 23
2022
Q3
$989K Hold
116,095
1.07% 34
2022
Q2
$825K Sell
116,095
-12,899
-10% -$107K 0.83% 35
2022
Q1
$1.5M Sell
128,994
-4,006
-3% -$48.5K 0.91% 32
2021
Q4
$1.7M Buy
133,000
+20,000
+18% +$253K 0.76% 38
2021
Q3
$1.54M Buy
113,000
+10,000
+10% +$140K 0.56% 44
2021
Q2
$1.66M Hold
103,000
0.55% 47
2021
Q1
$1.53M Buy
+103,000
New +$1.55M 0.59% 47

Other funds holding TELA

Jacob Asset Management of New York's TELA Position: Q3 2023 in Review

Jacob Asset Management of New York increased its TELA Bio (TELA) stake by 2.6% in Q3 2023, buying an estimated $37.2K and bringing the position to 159,775 shares worth $1.28M. The position accounts for 1.8% of the portfolio, ranked #21.

Jacob Asset Management of New York first reported a position in TELA in Q1 2021 and has held it in 11 quarters since. The position peaked at $1.7M in Q4 2021. 67 funds tracked by Wall St. Rank hold TELA as of Q3 2023.

  • Jacob Asset Management of New York held 159,775 shares of TELA Bio worth $1.28M as of Q3 2023.
  • Jacob Asset Management of New York bought 4,000 TELA Bio shares in Q3 2023, an estimated $37.2K.
  • TELA Bio made up 1.8% of Jacob Asset Management of New York's portfolio in Q3 2023, its #21 holding.
  • Jacob Asset Management of New York first reported a position in TELA Bio in Q1 2021 and has held it in 11 quarters since.
  • Jacob Asset Management of New York's TELA Bio position peaked at $1.7M in Q4 2021.
  • 67 funds tracked by Wall St. Rank held TELA Bio as of Q3 2023.

Based on Jacob Asset Management of New York's 13F filing for Q3 2023, filed 1 Nov 2023.